Merck & Company Inc (MRK)vsTruBridge Inc. (TBRG)
MRK
Merck & Company Inc
$148.10
-1.86%
HEALTHCARE · Cap: $355.10B
TBRG
TruBridge Inc.
$26.24
0.00%
HEALTHCARE · Cap: $391.33M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 19145% more annual revenue ($66.57B vs $345.90M). MRK leads profitability with a 4.8% profit margin vs 1.3%. TBRG appears more attractively valued with a PEG of 0.32. TBRG earns a higher WallStSmart Score of 45/100 (D).
MRK
Hold36
out of 100
Grade: F
TBRG
Hold45
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-77.2%
Fair Value
$83.04
Current Price
$148.10
$65.06 premium
Margin of Safety
+68.9%
Fair Value
$60.68
Current Price
$26.24
$34.44 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Generating 4.5B in free cash flow
Growing faster than its price suggests
Reasonable price relative to book value
Areas to Watch
Trading at 8.7x book value
ROE of 7.6% — below average capital efficiency
4.8% margin — thin
Elevated debt levels
0.0% earnings growth
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of 2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Free Cash Flow.
Bull Case : TBRG
The strongest argument for TBRG centers on PEG Ratio, Price/Book. PEG of 0.32 suggests the stock is reasonably priced for its growth.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 116.1x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.
Bear Case : TBRG
The primary concerns for TBRG are EPS Growth, Altman Z-Score, Market Cap. A P/E of 90.0x leaves little room for execution misses. Thin 1.3% margins leave little buffer for downturns.
Key Dynamics to Monitor
TBRG carries more volatility with a beta of 1.29 — expect wider price swings.
MRK is growing revenue faster at 5.1% — sustainability is the question.
MRK generates stronger free cash flow (4.5B), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - GENERAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TBRG scores higher overall (45/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →TruBridge Inc.
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company is headquartered in Mobile, Alabama.
Visit Website →Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?